Trial intelligence / Profile preview

Effect of pravastatin or fluvastatin with add-on valsartan on inflammatory markers and endothelial function in acute coronary syndrome

2004-003235-31Phase 4Terminated

Sponsor
Medical University of Innsbruck
Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of fluvastatin, pravastatin and valsartan in acute coronary syndrome (ACS) (4 arms), sponsored by Medical University of Innsbruck. Primary endpoint: high-sensitivity C-reactive protein. Started Jan 2005; status: terminated.

02

Drugs

fluvastatinpravastatinvalsartan
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on 2004-003235-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-003235-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call